Real-time enrollment status for this primary immunodeficiency clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 9:11 PM UTC
| NCT Number | NCT07076446 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Primary Immunodeficiency |
| Phase | Clinical Trial |
| Target Enrollment | 8 participants |
| Active Locations | 5 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | April 22, 2026 (Apr 22, 2026) |
As of June 1, 2026: Clinical trial NCT07076446 is currently active_not_recruiting participants. This clinical trial study for primary immunodeficiency is not currently accepting new participants at 5 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07076446 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07076446 was last updated Apr 22, 2026 (April 22, 2026). HelloStudys verifies this status automatically.